All terms in MESH
| Label | Id | Description |
|---|---|---|
| Enzyme Inhibitors | D004791 | [Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction.] |
| Carbonyl Cyanide m-Chlorophenyl Hydrazone | D002258 | [A proton ionophore. It is commonly used as an uncoupling agent and inhibitor of photosynthesis because of its effects on mitochondrial and chloroplast membranes.] |
| Hydrazones | D006835 | [Compounds of the general formula R:N.NR2, as resulting from the action of hydrazines with aldehydes or ketones. (Grant & Hackh's Chemical Dictionary, 5th ed)] |
| Nitriles | D009570 | [Organic compounds containing the -CN radical. The concept is distinguished from CYANIDES, which denotes inorganic salts of HYDROGEN CYANIDE.] |
| L-N(6)-(1-iminoethyl)lysine tetrazole-amide | C446200 | |
| Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone | D002259 | [A proton ionophore that is commonly used as an uncoupling agent in biochemical studies.] |
| Polycystic Kidney, Autosomal Dominant | D016891 | [Type 2 ADPKD is linked to gene mutation at the PKD2 locus on the long arm of CHROMOSOME 4., Type 1 ADPKD is linked to gene mutation at the PKD1 locus on the short arm of CHROMOSOME 16., Kidney disorders with autosomal dominant inheritance and characterized by multiple CYSTS in both KIDNEYS with progressive deterioration of renal function.] |
| Polycystic Kidney Diseases | D007690 | [Hereditary diseases that are characterized by the progressive expansion of a large number of tightly packed CYSTS within the KIDNEYS. They include diseases with autosomal dominant and autosomal recessive inheritance.] |
| Carotid Stenosis | D016893 | [Narrowing or stricture of any part of the CAROTID ARTERIES, most often due to atherosclerotic plaque formation. Ulcerations may form in atherosclerotic plaques and induce THROMBUS formation. Platelet or cholesterol emboli may arise from stenotic carotid lesions and induce a TRANSIENT ISCHEMIC ATTACK; CEREBROVASCULAR ACCIDENT; or temporary blindness (AMAUROSIS FUGAX). (From Adams et al., Principles of Neurology, 6th ed, pp 822-3)] |
| Arterial Occlusive Diseases | D001157 | [Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.] |
| Endarterectomy, Carotid | D016894 | [The excision of the thickened, atheromatous tunica intima of a carotid artery.] |
| Endarterectomy | D004691 | [Surgical excision, performed under general anesthesia, of the atheromatous tunica intima of an artery. When reconstruction of an artery is performed as an endovascular procedure through a catheter, it is called ATHERECTOMY.] |
| Culture Media, Serum-Free | D016895 | [CULTURE MEDIA free of serum proteins but including the minimal essential substances required for cell growth. This type of medium avoids the presence of extraneous substances that may affect cell proliferation or unwanted activation of cells.] |
| Culture Media | D003470 | [Any liquid or solid preparation made specifically for the growth, storage, or transport of microorganisms or other types of cells. The variety of media that exist allow for the culturing of specific microorganisms and cell types, such as differential media, selective media, test media, and defined media. Solid media consist of liquid media that have been solidified with an agent such as AGAR or GELATIN.] |
| Prognosis | D011379 | [A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations.] |
| Outcome Assessment (Health Care) | D017063 | [Research aimed at assessing the quality and effectiveness of health care as measured by the attainment of a specified end result or outcome. Measures include parameters such as improved health, lowered morbidity or mortality, and improvement of abnormal states (such as elevated blood pressure).] |
| Respiratory Burst | D016897 | [A large increase in oxygen uptake by neutrophils and most types of tissue macrophages through activation of an NADPH-cytochrome b-dependent oxidase that reduces oxygen to a superoxide. Individuals with an inherited defect in which the oxidase that reduces oxygen to superoxide is decreased or absent (GRANULOMATOUS DISEASE, CHRONIC) often die as a result of recurrent bacterial infections.] |
| Cell Respiration | D019069 | [The metabolic process of all living cells (animal and plant) in which oxygen is used to provide a source of energy for the cell.] |
| Interferon-alpha | D016898 | [One of the type I interferons produced by peripheral blood leukocytes or lymphoblastoid cells. In addition to antiviral activity, it activates NATURAL KILLER CELLS and B-LYMPHOCYTES, and down-regulates VASCULAR ENDOTHELIAL GROWTH FACTOR expression through PI-3 KINASE and MAPK KINASES signaling pathways.] |
| Interferon Type I | D007370 | [Interferon secreted by leukocytes, fibroblasts, or lymphoblasts in response to viruses or interferon inducers other than mitogens, antigens, or allo-antigens. They include alpha- and beta-interferons (INTERFERON-ALPHA and INTERFERON-BETA).] |